| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1378737 | Bioorganic & Medicinal Chemistry Letters | 2005 | 6 Pages |
Abstract
A series of 1,3,4-trisubstituted pyrrolidine CCR5 receptor antagonists containing a variety of fused heterocycles at the 4-position of the piperidine side chain has been discovered, which are orally bioavailable with potent anti-HIV activity.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Dooseop Kim, Liping Wang, Jeffrey J. Hale, Christopher L. Lynch, Richard J. Budhu, Malcolm MacCoss, Sander G. Mills, Lorraine Malkowitz, Sandra L. Gould, Julie A. DeMartino, Martin S. Springer, Daria Hazuda, Michael Miller, Joseph Kessler, Renee C. Hrin,